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Transcatheter Arterial Embolization of
Arterial Esophageal Bleeding with the 
Use of N-Butyl Cyanoacrylate
Objective: To evaluate the clinical efficacy and safety of a transcatheter arterial
embolization (TAE) with N-butyl cyanoacrylate (NBCA) for the treatment of arteri-
al esophageal bleeding.
Materials and Methods: Between August 2000 and April 2008, five patients
diagnosed with arterial esophageal bleeding by conventional angiography, CT-
angiography or endoscopy, underwent a TAE with NBCA. We mixed NBCA with
iodized oil at ratios of 1:1 to 1:4 to supply radiopacity and achieve a proper poly-
merization time. After embolization, we evaluated the angiographic and clinical
success, recurrent bleeding, and procedure-related complications.
Results: The bleeding esophageal artery directly originated from the aorta in
four patients and from the left inferior phrenic artery in one patient. Although four
patients had an underlying coagulopathy at the time of the TAE, angiographic
and clinical success was achieved in all five patients. In addition, no procedure-
related complications such as esophageal infarction were observed during this
study. 
Conclusion: NBCA can be an effective and feasible embolic agent in patients
with active arterial esophageal bleeding, even with pre-existing coagulopathy.
rterial esophageal bleeding is a relatively uncommon cause of acute
upper gastrointestinal hemorrhaging compared to bleeding caused by
varices related to portal hypertension (1). The traditional first line of
therapy for esophageal hemorrhaging is an endoscopy (1). However, with the
advancement of technology, the transcatheter arterial embolization (TAE) has been an
important and powerful treatment option for acute gastrointestinal hemorrhaging (2-
4). Few case reports have described the treatment modalities for arterial bleeding of
the esophagus and the use of various embolic materials such as gelatin sponges,
microcoils and polyvinyl alcohol particles to embolize arterial esophageal bleeding (5-
8). This is attributed to the reluctance of many practitioners to use such a tissue-
adhesive, liquid embolic agent such as N-butyl cyanoacrylate (NBCA) to treat acute
gastrointestinal hemorrhaging due to the concern of ischemic injury and the difficulty
in handling the material. In this current study, we report the clinical efficacy and safety
of TAE using NBCA for treatment of arterial esophageal bleeding.
MATERIALS AND METHODS
Between July 2000 and June 2008, five patients underwent a TAE for treatment of
arterial esophageal bleeding at our institution. The patients included four men and one
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Awoman, with an age range of 41-72 years (mean age, 59
years). Prior endoscopic treatment had failed in two
patients and was not attempted in three patients because a
skillful endoscopist was not available at that time or
patients could not cooperate performing endoscopic
treatment. We have described two of these cases in a
previous report (9). Our Institutional Review Board
approved this study, and patient informed consent was
waived due to the retrospective nature of the study.
We used NBCA (Histoacryl; B. Braun, Melsungen,
Germany) as an embolic agent in all five patients. The
choice of NBCA as an embolic material in gastrointestinal
bleeding patients has been common at our institution if we
succeeded in the superselection of the small bleeding
artery. We performed a diagnostic angiography to localize
the bleeding site after a common femoral artery puncture.
Our routine angiography protocol included a thoracic
aortography and left gastric angiography. If we failed to
show evidence of bleeding on aortography and left gastric
angiography, we performed a selective angiography of the
intercostal artery, bronchial artery, left inferior phrenic
artery and tried to search for the esophageal artery directly
from the aorta. After confirming the active bleeding, we
advanced a 2.4-Fr tip microcatheter (Microferret; Cook,
Bloomington, IN) or 2.0-Fr tip microcatheter (Progreat;
Terumo, Tokyo, Japan) as close as possible into the
bleeding esophageal artery. Next, we mixed NBCA with
iodized oil (Lipiodol; Andre Guerbet, Aulnay-Sous-Bois,
France) at ratios varying from 1:1 to 1:4. Prior to injection
of the NBCA mixture, we flushed the microcatheter with a
5% dextrose solution to prevent premature polymeriza-
tion of the mixture within the microcatheter. We injected
the NBCA mixture using a 1 mL syringe under fluoro-
scopic monitoring. Next, we performed a post-emboliza-
tion angiography to evaluate the effectiveness of the
treatment.
We retrospectively evaluated the technical and clinical
success, recurrent bleeding, procedure-related complica-
tions and clinical outcomes of each patient. We defined
technical success as a successful superselection of the
bleeding vessel and delivery of the NBCA mixture, as well
as an angiography after embolization that showed no
evidence of active bleeding (i.e., the presence of a
pseudoaneurysm or extravasation of contrast agent). We
defined clinical success as clinical improvement without
evidence of bleeding for the next three days (i.e., clearing
of the nasogastric aspirate and stabilization of the
hemoglobin level). Patients who met one of the following
criteria were considered to have coagulopathy: a
prothrombin ratio greater than 1.5, a partial thromboplas-
tin time greater than 45 seconds or a platelet count less
than 80,000/μ L (2, 10, 11).
RESULTS
The clinical and angiographic data of the five patients are
summarized in Table 1. We diagnosed four of the five
patients with coagulopathy at the time of embolization. As
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Table 1. Clinical and Angiographic Data of Five Patients with Arterial Esophageal Bleeding
Vital Sign before  Vital Sign after 
No./Age/ Underlying
Cause  Origin of  Location of  Coagulo- Angio- Embolization Embolization Result 
Sex Disease
of  Esophageal  Bleeding  pathy graphic  Mean  Heart  Mean  Heart  of 
Bleeding Artery Site Finding Blood  Rate Blood  Rate Admission
Pressure Pressure
1/58/F Corrosive  Esophageal Aorta Distal  Present Extravasation 82 130 102 104 Expired due to 
esophageal  candidiasis esophagus sepsis 4 
stricture  days later
2/64/M Subtotal  Marginal  Left  Distal  Present Extravasation 88 120 96 114 Expired due to 
gastrectomy  ulcer inferior  esophagus sepsis 29 
due to gastric  phrenic  days later
cancer artery
3/41/M Liver  Benign  Aorta Distal  Present Extravasation 74 124 82 86 Expired due to 
transplantation ulcer esophagus multiorgan failure
recipient 28 days later
4/67/M Intracerebral  Mallory- Aorta Distal  Absent Extravasation 86 118 130 106 Discharged 
hemorrhage Weiss tear esophagus without event
5/57/M Angiosarcoma Benign  Aorta  Distal  Present Extravasation 96 116 101 102 Expired due to 
in liver ulcer esophagus sepsis 29 
days laterwell, four of five patients had bleeding esophageal arteries,
which originated directly from the aorta (Fig. 1). The fifth
patient (patient 2) had a bleeding esophageal artery that
originated from the left inferior phrenic artery (Fig. 2). For
all the five patients, the bleeding site was located at the
distal esophagus. Further, the angiographic findings in all
five patients indicated extravasation of contrast agent.
Each patient showed clearing of the nasogastric aspirate
and stabilization of the hemoglobin level without
additional transfusion after embolization, and in turn
achieved technical and clinical success. Further, there was
no evidence of symptomatic esophageal infarction or other
major complications directly related to NBCA emboliza-
tion in any of the patients. One patient (patient 4)
underwent a follow-up endoscopic evaluation five days
after the embolization, and we found no esophageal
ischemia. In spite of the successful embolizations, four
patients expired during hospitalization due to other
underlying conditions such as sepsis or multi-organ failure.
The fifth patient recovered without further complications.
DISCUSSION
N-butyl cyanoacrylate starts to polymerize with the
bonding of the ethylene units when exposed to anions such
as the hydroxyl moieties in water or numerous anions
present in blood. Because of its low viscosity, NBCA is
easy to deliver through microcatheters even if the
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Fig. 1. 41-year-old man (patient 3) presenting with arterial esophageal bleeding and underwent liver transplant 30 days prior.
A. Selective angiography of esophageal artery arising from descending thoracic aorta shows extravasation of contrast media (arrows) in
distal esophagus.
B. Image obtained after embolization shows N-butyl cyanoacrylate and Lipiodol mixture in esophageal artery (arrow) and in lumen of
esophagus (arrowhead).
C. Selective angiography of esophageal artery after performing embolization shows no evidence of extravasation of contrast media. Note
subtraction artifact (arrow) caused by N-butyl cyanoacrylate and Lipiodol mixture in esophageal artery.
ABC
Fig. 2. 64-year-old man (patient 2) with
arterial esophageal bleeding that
underwent subtotal gastrectomy 49 days
prior.
A. Selective angiography of left inferior
phrenic artery shows extravasation of
contrast media (arrowhead) originating
from esophageal branch (arrow).
B. Image during embolization shows N-
butyl cyanoacrylate and Lipiodol mixture
in esophageal artery (arrowhead) and in
lumen of esophagus (open arrowhead).
Note tip (arrow) of microcatheter in
esophageal branch.
ABcatheters have tortuous running pathways. Moreover, the
lack of radiopacity and polymerization time when in
contact with blood can be modified by the addition of an
oily contrast medium such as Lipiodol (12, 13). This allows
the operator to control the degree of distal vessel penetra-
tion as well as facilitate the occlusion at or significantly
beyond the catheter tip. In effect, when blood velocity is
low and the catheter tip cannot be placed near the locus of
hemorrhaging, lowering the concentration NBCA and
releasing it in a far proximity to the target may allow the
intended goal to take effect. In turn, when blood velocity is
high and the catheter tip can be placed near the locus of
hemorrhaging, increasing the concentration of NBCA and
releasing it in close proximity to the target, may also allow
the intended goal to take effect. Furthermore, as the
embolization time was significantly shorter in patients who
received NBCA, compared to patients that did not receive
the agent, this situation is advantageous to the operator in
an urgent or emergency situation (14).
The arterial blood supply of the esophagus is divided into
three parts. Primarily, the descending branches of the
inferior thyroid artery supply the cervical esophagus.
Branches of the bronchial arteries, and one or two
esophageal arteries that arise directly from the aorta,
supply the midthoracic portion. Lastly, branches of the left
gastric or left inferior phrenic arteries supply the distal
portion (6, 15). Interventional radiologists should be aware
of variations in the arterial blood supply of the esophagus
for a complete investigation of a bleeding focus. Branches
of the subclavian, thyroidea ima, common carotid, or
superior thyroid arteries may also supply the cervical
esophagus. Branches of the right third or fourth intercostal
arteries may also supply the midthoracic esophagus. Lastly,
branches from the celiac, splenic, short gastric, or left
hepatic arteries may supply the distal esophagus (6, 16).
The origins of previously embolized esophageal arteries
varied and have included an esophageal branch that arose
from the thoracic aorta (6, 8), an esophageal branch that
arose from the right intercostal artery (7) and an
esophageal branch that arose from the left gastric artery
and inferior phrenic artery (5). In our study, the embolized
esophageal branches originated from the aorta in four
patients, and from the left inferior phrenic artery in one
patient. Also, although all five patients had bleeding at the
distal esophagus, there was no bleeding from the left
gastric artery.
The various types of embolic materials used for the
embolization of esophageal artery include gelatin sponge
particles (5, 6), polyvinyl alcohol particles (7), and
microcoils (8). As the esophageal arteries form collateral
capillary networks before they penetrate the esophageal
muscle layer and perfuse the submucosa (8), they can
cause back bleeding (hemorrhaging from potential collat-
eral channels) that is of concern. For this reason, in a case
report on embolization of arterial esophageal bleeding
with microcoils, Vogten et al. (8) catheterized another two
esophageal branches after embolization just proximal and
distal to the embolized branch. In our study, back bleeding
from collateral channels did not occur. We believe that due
to its liquid characteristics, NBCA can penetrate potential
collateral channels and effectively embolize the channels
with a single injection if properly mixed with oily contrast
medium. Recently, NBCA has been used as an embolic
agent in upper gastrointestinal bleeding patients with
promising results (9, 17). In addition, Toyoda et al. (14)
reported a significant reduction in the time of completion
for a TAE with NBCA for the treatment of gastric or
duodenal ulcer bleeding than TAE without NBCA. In a
study of the embolization of acute upper gastrointestinal
bleeding, Lee et al. (17) reported the practical application
of controlling NBCA concentration when the bleeding
artery could not be catheterized. They occluded the distal
portion to the orifice of the bleeding vessel with a very
slow injection rate of a higher concentration (40%) of
NBCA. Next, the microcatheter was withdrawn to the
proximal portion for continuous injection. If the catheter
could not reach the distal portion of the orifice of the
bleeding artery, 20-30% NBCA was injected at a proximal
segment.
The diagnosis of coagulopathy in patients has been
shown to adversely affect the success rate of embolother-
apy in gastrointestinal bleeding, as well as an increase in
the odds for clinical failure, which ranges from 2.9 to 19.46
(2, 10, 11). However, previous studies have reported that
the use of NBCA was accompanied with a high
angiographic and clinical success rate for cases of upper
gastrointestinal bleeding in patients with coagulopathy (9,
17) since NBCA does not require the coagulation process
for its effect. Similarly, although four of the five patients in
our study had coagulopathy, we achieved technical and
clinical success in all five case studies.
With the advancement of microcatheter and embolic
agents, TAE quickly has become a safe and effective
treatment for many cases of upper gastrointestinal bleeding
(1, 9, 17). Although the first line therapy for esophageal
hemorrhage is endoscopy (1), a TAE can be an alternative
option for arterial esophageal bleeding when a skillful
endoscopist is not available, endoscopic hemostasis fails, or
patients could not cooperate to undergoing endoscopic
treatment.
Our study has several limitations. First, the study popula-
tion is so small because arterial esophageal bleeding is a
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month after the embolization, due to various underlying
disease. 
In conclusion, we suggest that NBCA can be an effective
and feasible embolic agent in patients with arterial
esophageal bleeding, even in patients with coagulopathy.
Patients with arterial esophageal bleeding should undergo
a careful search for the esophageal branch that directly
arises from the aorta.
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